Arterial stenosis and electrophysiological nerve dysfunction in type 2 diabetes: clinical evidence from GEE models and transcriptomic pathway analysis.

Overview

1. Department of Neurology, Jinshan Hospital Affiliated to Fudan University, Shanghai, China
2. Department of Echocardiography, Jinshan Hospital Affiliated to Fudan University, Shanghai, China

Abstract

Background: Diabetic peripheral neuropathy (DPN) is a common disabling complication of type 2 diabetes (T2D), yet the contribution of systemic arterial stenosis to electrophysiological nerve dysfunction remains incompletely characterized.

Objective: To examine whether carotid arterial stenosis (CASD) and lower-limb arterial stenosis (LWASD) are associated with multi-nerve conduction abnormalities in T2D, and to explore supportive molecular signatures using transcriptomic analysis.

Methods: In this retrospective cross-sectional study, 202 patients with T2D underwent bilateral carotid and lower-limb ultrasonography and standardized nerve conduction testing. Nerve dysfunction was quantified using 16 binary electrophysiological abnormality indicators. Generalized estimating equation (GEE) models estimated marginal associations between stenosis grades and nerve abnormality, adjusting for age and sex, with an expanded model additionally adjusting for HbA1c, LDL-cholesterol, and triglycerides to assess robustness to metabolic confounding. Patient-level abnormality burden was evaluated using a binomial model (abnormal indicators out of those assessed). Transcriptomic differential expression and pathway enrichment were performed using the public microarray dataset GSE95849 to provide supportive systemic molecular context.

Results: LWASD was significantly associated with increased odds of nerve conduction abnormality and remained robust after metabolic adjustment (OR ≈ 1.5 per grade increase, p< 0.001), whereas CASD showed weaker and non-significant associations in the primary nerve-level models. Nerve-specific analyses suggested stronger signals in distal lower-limb measures consistent with a length-dependent pattern. Transcriptomic analyses highlighted enrichment of pathways related to hypoxia responses, inflammatory signaling, mitochondrial dysfunction, and neuronal maintenance.

Conclusion: Lower-limb arterial stenosis is independently associated with a greater burden of electrophysiological nerve abnormalities in T2D beyond key metabolic parameters. Transcriptomic signatures support a vascular–hypoxic–inflammatory context consistent with mechanisms implicated in diabetic complications; however, causal direction cannot be inferred from cross-sectional data.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

Datasets cited

• geo:GSE95849, at NCBI GEO; found in the text, “Introduction”

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 7 authors, 8 keywords, 14 MeSH terms, 19 references.

Cite

This paper

Zhao, X.-q., Huang, L.-j., Yao, K., Zeng, W.-c., Zu, H.-b., Wu, J.-f., & Zhang, J.-f. (2026). Arterial stenosis and electrophysiological nerve dysfunction in type 2 diabetes: clinical evidence from GEE models and transcriptomic pathway analysis. Frontiers in endocrinology, 17, 1758863. https://doi.org/10.3389/fendo.2026.1758863

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1177/17448069261435315

Consensus co-expression analysis identifies a common set of co-expressed genes associated with diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy.

Journal: Molecular pain

In common: genetics / omics, other condition, 2 references

[2] doi:10.1371/journal.pone.0306424

Single-cell transcriptome analysis reveals distinct cell populations in dorsal root ganglia and their potential roles in diabetic peripheral neuropathy.

Journal: PloS one

In common: genetics / omics, other condition, 1 reference

[3] doi:10.3389/fchem.2026.1739085

Inflammatory and neurotoxic risk of atorvastatin in diabetic peripheral neuropathy: TNF-centered evidence integrating network toxicology, scRNA-Seq, and cell validation.

Journal: Frontiers in chemistry

In common: genetics / omics, other condition, 1 reference

[4] doi:10.1038/s41467-025-59562-z

Dysregulated mast cell activation induced by diabetic milieu exacerbates the progression of diabetic peripheral neuropathy in mice.

Journal: Nature communications

In common: other condition, 1 reference

[5] doi:10.26508/lsa.202402791

Vascular dysfunction is at the onset of oxaliplatin-induced peripheral neuropathy symptoms in mice.

Journal: Life science alliance

In common: other condition, 1 reference

[6] doi:10.1038/s41598-026-48278-9

Biphasic modulation of large-fiber excitability accompanied by dynamic nerve-intrinsic immune activation following CFA-induced peripheral inflammation in mice.

Journal: Scientific reports

In common: genetics / omics, 1 reference

[7] doi:10.1038/s41597-025-06498-0

The ASPIRE Research Institute Dataset: Building a Foundation for Brain Health Research in the United Arab Emirates.

Journal: Scientific data

In common: 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.